# A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries

> **NCT01677598** · — · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 169 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** No intervention

## Key facts

- **NCT ID:** NCT01677598
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-02
- **Primary completion:** 2013-11-30
- **Final completion:** 2013-11-30
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677598, "A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01677598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*